Trial Profile
Assessment of body composition changes after Levosimendan treatment in patients with advanced heart failure
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Sep 2018
Price :
$35
*
At a glance
- Drugs Levosimendan (Primary)
- Indications Chronic heart failure
- Focus Pharmacodynamics
- Acronyms BCC - LEVO
- 07 Sep 2018 New trial record